Management of the persistent ductus arteriosus in infants of very low birth weight: Early and long-term results

Interactive Cardiovascular and Thoracic Surgery

Volumn 3, Issue 3, 2004, Pages 460-464

  Korbmacher, B ^a   Lemburg, S ^a   Zimmermann, N ^a   Stannigel, H ^a   Godehardt, E ^a   Heusch, A ^a   Schipke, J D ^a   Gams, E ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Persistent ductus arteriosus; Surgical closure; Very low weight birth infants

Indexed keywords

INDOMETACIN;

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBRAL PALSY; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEMODYNAMIC MONITORING; HUMAN; HYPOXIA; INFANT; LANGUAGE DEVELOPMENT; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MORTALITY; PATENT DUCTUS ARTERIOSUS; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 4143076896     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.icvts.2004.03.007     Document Type: Conference Paper

References (15)

1. Hammerman C. Patent ductus arteriosus (clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment). Clinics in Perinatology. 22:1995;457-479
2. Todd D.A., Jana A., John E. Chronic oxygen dependency in infants born at 24-32 weeks of gestation: the role of antenatal and neonatal factors. J Paediatr Child Health. 33:1997;402-407
3. Giedion A., Haefliger H., Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEEP). Paediat Radiol. 1:1973;145-152
4. Evans N. Diagnosis of patent ductus arteriosus in the preterm newborn. Arch Dis Child. 68:1993;58-61
5. Trus T., Winthrop A.L., Pie S., Shah J., Langer J.C., Lau G.Y.P. Optimal management of patent ductus arteriosus in the neonate weighting less than 800 g. J Pediatr Surg. 28:1993;1137-1139
6. van Overmeire B., Brus F., van Acker K.J., van der Auwera J.C., Schasfoort M. Aspirin versus Indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatr Res. 38:1995;886-891
7. Romagnoli C., Zecca E., Papacci P., de Carolis M.P., Giannini R., Gallini F., Tortorolo G. Furosemid does not prevent the indomethacin - induced renal side effects in preterm infants. Clin Pharmacol Ther. 62:1997;181-186
8. Nakamura T., Tamura M., Kadowaki S., Sasano T. Low-dose continuous indomethacin in early days of age reduce the incidence of symptomatic patent ductus arteriosus without adverse effects. Am J Perinatol. 17:2000;271-275
9. Van Overmeire B., Van de Broek H., Van Laer P., Weyler J., Vanhaesebrouk P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr. 138:2001;205-211
10. Van Overmeire B., Smets K., Lecoutere D., Van de Broek H., Weyler J., Degroote K., Langhendries J.P. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med. 343:2000;674-681
11. Satterwhite C., Cassady G. Patent ductus arteriosus in the very low birth weight infant: summary of incidence, management and outcome. Clin Res. 24:1980;874A
12. Kunnas M. Mortality of premature infants according to the temperature on admission to hospital. Ann Paediatr Fenn. 14:1968;98-101
13. Coster D.C., Gorton M.E., Grooters R.K., Thieman K.C., Schneider R.F., Soltanzadeh H. Surgical closure of the patent ductus arteriosus in the neonatal intensive care unit. Ann Thorac Surg. 48:1989;386-389
14. Kitterman J.A., Edmunds L.H., Gregory G.A., Heymann M.A., William B.C., Tooley H., Rudolph A.M. Patent ductus arteriosus in premature infants - incidence, relation to pulmonary disease and management. N Engl J Med. 287:1972;473-477
15. Valdes-Cruz L.M., Dudell G.G. Specificity and accuracy of echocardiographic and clinical criteria for diagnosis of patent ductus arteriosus in fluid-restricted infants. J Pediatr. 98:1981;298-305